For instance, the ability of PPARβ/δ activators to raise HDL-cholesterol levels in rodents has been demonstrated in primates, but the effects of these drugs on the prevention of obesity in rodents were not observed in primates. The gene discussed is PPARD; the disease is obesity due to melanocortin 4 receptor deficiency.